日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cumulative deficits frailty index and relationship status predict survival in multiple myeloma

累积缺陷虚弱指数和关系状况可预测多发性骨髓瘤患者的生存期

Abdallah, Nadine; Dizona, Paul; Kumar, Amanika; LaPlant, Betsy; Menser, Terri; Schaeferle, Gavin; Aug, Sarah; Weivoda, Megan; Dispenzieri, Angela; Buadi, Francis K; Warsame, Rahma; Cook, Joselle; Lacy, Martha Q; Hayman, Suzanne; Gertz, Morie A; Rajkumar, S Vincent; Kumar, Shaji K

Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study

癌症和白血病B组10102(Alliance)1/2期研究结果

Luskin, Marlise R; Yin, Jun; Lozanski, Gerard; Curran, Emily; Malnassy, Gregory; Mrózek, Krzysztof; Bloomfield, Clara D; Cataland, Spero R; Fulton, Noreen; Kolitz, Jonathan; Laplant, Betsy; Kour, Oudom; Powell, Bayard L; Vij, Ravi; Wang, Eunice S; Grinblatt, David; Stone, Richard M; Uy, Geoffrey L; Larson, Richard A; Stock, Wendy

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408

结外疾病对滤泡性淋巴瘤PET/CT预后的影响:一项基于ECOG 2408的验证研究结果

St-Pierre, Frederique; Broski, Stephen M; Sun, Zequn; Kocherginsky, Masha; LaPlant, Betsy; Maurer, Matthew J; Quon, Andrew; Baratto, Lucia; Savas, Hatice; Kostakoglu, Lale; Winter, Jane N; Witzig, Thomas E; Kahl, Brad; Evens, Andrew M; Gordon, Leo I

High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations

对患有 TET2 突变的 CCUS 患者进行高剂量静脉注射抗坏血酸治疗

Xie, Zhuoer; Fernandez, Jenna; Lasho, Terra; Finke, Christy; Amundson, Michelle; McCullough, Kristen B; LaPlant, Betsy R; Mangaonkar, Abhishek A; Gangat, Naseema; Reichard, Kaaren K; Elliott, Michelle; Witzig, Thomas E; Patnaik, Mrinal M

Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma

埃洛妥珠单抗联合泊马度胺和地塞米松治疗达雷妥尤单抗难治性多发性骨髓瘤的II期试验

Parrondo, Ricardo D; LaPlant, Betsy R; Elliott, Jamie; Fernandez, Andre; Flott, Caitlin J; Arrington, Diedre; Chapin, Dustin; Brown, Jade; Das, Saurav; Roy, Vivek; Chanan-Khan, Asher A; Ailawadhi, Sikander

Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials

骨髓活检在美国国家癌症研究所国家临床试验网络滤泡性淋巴瘤临床试验疗效评估中的意义

Rutherford, Sarah C; Yin, Jun; Pederson, Levi; Perez Burbano, Gabriela; LaPlant, Betsy; Shadman, Mazyar; Li, Hongli; LeBlanc, Michael L; Kenkre, Vaishalee P; Hong, Fangxin; Blum, Kristie A; Dockter, Travis; Martin, Peter; Jung, Sin-Ho; Grant, Barbara; Rosenbaum, Cara; Ujjani, Chaitra; Barr, Paul M; Unger, Joseph M; Cheson, Bruce D; Bartlett, Nancy L; Kahl, Brad; Friedberg, Jonathan W; Mandrekar, Sumithra J; Leonard, John P

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

AT-101 增强来那度胺对多发性骨髓瘤患者的抗肿瘤活性。

Ailawadhi Sikander, Parrondo Ricardo D, Dutta Navnita, Han Bing, Ciccio Gina, Cherukuri Yesesri, Alegria Victoria R, LaPlant Betsy R, Roy Vivek, Sher Taimur, Edwards Brett, Lanier Stephanie, Manna Alak, Heslop Keisha, Caulfield Thomas, Maldosevic Emir, Storz Peter, Manochakian Rami, Asmann Yan, Chanan-Khan Asher A, Paulus Aneel

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts

PET2 反应与新诊断弥漫性大 B 细胞淋巴瘤患者的生存率相关:两项独立前瞻性队列研究的结果

Desai, Sanjal H; Pederson, Levi; LaPlant, Betsy; Mwangi, Raphael; Maurer, Matthew; Young, Jason R; Macon, William R; King, Rebecca L; Wang, Yucai; Cerhan, James R; Feldman, Andrew; Inwards, David J; Micallef, Ivana; Johnston, Patrick; Porrata, Luis F; Ansell, Stephen M; Habermann, Thomas M; Witzig, Thomas E; Nowakowski, Grzegorz S

Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind?

器官功能相关的临床试验入选标准对弥漫性大B细胞淋巴瘤患者的影响:哪些患者会被排除在外?

Khurana, Arushi; Mwangi, Raphael; Nowakowski, Grzegorz S; Habermann, Thomas M; Ansell, Stephen M; LaPlant, Betsy R; Link, Brian K; Cerhan, James R; Maurer, Matthew J; Witzig, Thomas E

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study

来那度胺联合 R-CHOP 方案治疗由滤泡性淋巴瘤转化而来的初治弥漫性大 B 细胞淋巴瘤,可获得较高的缓解率和无进展生存期:来自 II 期 MC078E 研究的结果

Desai, Sanjal H; LaPlant, Betsy; Macon, William R; King, Rebecca L; Wang, Yucai; Inwards, David J; Micallef, Ivana; Johnston, Patrick B; Porrata, Luis F; Ansell, Stephen M; Habermann, Thomas M; Witzig, Thomas E; Nowakowski, Grzegorz S